Researchers have determined why a certain class of diabetes drugs leads to weight gain and have found that the molecular system involved (PPAR-gamma found in the brain) is also triggered by consumption of high-fat foods. The study could lead to the modification of existing diabetes therapies and even dietary recommendations to limit the action of this nuclear receptor in the brain.